Clinical Trials Directory

Trials / Completed

CompletedNCT06383494

GMA-Tulip, I-gel and the LMA-Supreme (LMA-S) Devices in Airway Management (GLAM-I)

GMA-Tulip, I-gel and the LMA-Supreme (LMA-S) Devices in Airway Management Under General Anesthesia, a Randomized Controlled Study (GLAM-I)

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
498 (actual)
Sponsor
Zhejiang Cancer Hospital · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

Patients were randomly assigned to three supraglottic airway devices (SADs) groups for airway management after anesthesia induced. Fiberoptic bronchoscope (FB) guided glottic exposure grading was performed and other airway management quality was recorded.

Detailed description

Mechanical ventilation was volume controlled and time cycled with tidal volumes (6-8 ml/kg) set to maintain peak inspiratory pressures of less than 20 cm H2O and ventilatory frequency adjusted to maintain end-tidal carbon dioxide (PETCO2) at 35-45 mmHg. Then a fiberoptic bronchoscope was passed through airway tube into the device to perform glottic exposure grading. Peak airway pressure, incidence of pharyngalgia, bleeding, hoarseness, and dysphagia were recorded.

Conditions

Interventions

TypeNameDescription
DEVICELMA supreme groupPatient in this group received LMA supreme (one of laryngeal airway management device) for airway management during general anesthesia
DEVICEI-gel groupPatient in this group received I-gel laryngeal (one of laryngeal airway management device) for airway management during general anesthesia
DEVICEGMA-TulipPatient in this group received GMA-Tulip (one of laryngeal airway management device) for airway management during general anesthesia

Timeline

Start date
2024-04-30
Primary completion
2024-12-31
Completion
2025-01-01
First posted
2024-04-25
Last updated
2026-01-08

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06383494. Inclusion in this directory is not an endorsement.